PerkinElmer Inc (PKI) - Financial and Strategic SWOT Analysis Review

April 2021 | 75 pages | ID: PCC3F5ABCB1EN
GlobalData

Abstracts

PerkinElmer Inc (PKI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

PerkinElmer Inc (PerkinElmer) is a provider of detection and imaging technologies, consumables, informatics solutions, accessories and services. The company’s major products include cytogenetics reagents, ELISA Kits, tissue biomarker reagents, atomic spectroscopy instruments, chromatography instruments, molecular spectroscopy, newborn screening instruments and thermal analysis instruments. It offers reagents, instruments, assay platforms and software to hospitals, clinicians, medical labs and medical research professionals. PerkinElmer also offers cord blood and tissue banking, laboratory and research services, among others. Its products are used in various applications, including atomic spectroscopy, cell imaging and analysis, chromatography, analysis and detection, DNA/RNA isolation, in vivo imaging, molecular spectroscopy, protein analysis and detection, and tissue imaging, among others. The company operates in Asia-Pacific, Europe and North America. PerkinElmer is headquartered in Waltham, Massachusetts, US.

PerkinElmer Inc Key Recent Developments

Mar 17,2021: PerkinElmer further expands industry-leading signals informatics capabilities in biologics drug discovery
Mar 10,2021: PerkinElmer unveils assays to identify mutations linked to SARS-CoV-2
Mar 09,2021: PerkinElmer Completes Acquisition of Oxford Immunotec Global PLC
Feb 22,2021: PerkinElmer provides an update on Valencia Branch Laboratory’s accreditation process
Feb 16,2021: PerkinElmer to Present at Cowen Health Care Conference

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

PerkinElmer Inc - Key Facts
PerkinElmer Inc - Key Employees
PerkinElmer Inc - Key Employee Biographies
PerkinElmer Inc - Major Products and Services
PerkinElmer Inc - History
PerkinElmer Inc - Company Statement
PerkinElmer Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture

SECTION 2 – COMPANY ANALYSIS

Company Overview
PerkinElmer Inc - Business Description
Business Segment: Diagnostics
Overview
Performance
Key Stats
Business Segment: Discovery & Analytical Solutions
Overview
Performance
Key Stats
Geographical Segment: International
Target Markets
Performance
Geographical Segment: The US
Performance
R&D Overview
PerkinElmer Inc - Corporate Strategy
PerkinElmer Inc - SWOT Analysis
SWOT Analysis - Overview
PerkinElmer Inc - Strengths
PerkinElmer Inc - Weaknesses
PerkinElmer Inc - Opportunities
PerkinElmer Inc - Threats
PerkinElmer Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

PerkinElmer Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
PerkinElmer Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
PerkinElmer Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Mar 17, 2021: PerkinElmer further expands industry-leading signals informatics capabilities in biologics drug discovery
Mar 10, 2021: PerkinElmer unveils assays to identify mutations linked to SARS-CoV-2
Feb 22, 2021: PerkinElmer provides an update on Valencia Branch Laboratory’s accreditation process
Feb 16, 2021: PerkinElmer to Present at Cowen Health Care Conference
Feb 16, 2021: PerkinElmer launches first cell painting Kit
Feb 04, 2021: PerkinElmer’s Horizon Discovery CHOSOURCE cell line supports Trinomab Biotech’s development of the world-first, Tetanus Toxin mAb drug for clinical trials
Feb 02, 2021: PerkinElmer announces financial results for the fourth quarter and full year of 2020
Jan 14, 2021: EUROIMMUN launches SARS-CoV-2 Test System to detect T-cell response
Dec 14, 2020: PerkinElmer invests in Carterra, the leader in label-free high throughput antibody screening and characterization
Nov 30, 2020: Charnwood Lighthouse Lab goes live processing thousands of COVID-19 tests per day with PerkinElmer Solutions

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

PerkinElmer Inc, Key Facts
PerkinElmer Inc, Key Employees
PerkinElmer Inc, Key Employee Biographies
PerkinElmer Inc, Major Products and Services
PerkinElmer Inc, History
PerkinElmer Inc, Other Locations
PerkinElmer Inc, Subsidiaries
PerkinElmer Inc, Joint Venture
PerkinElmer Inc, Key Competitors
PerkinElmer Inc, Ratios based on current share price
PerkinElmer Inc, Annual Ratios
PerkinElmer Inc, Annual Ratios (Cont...1)
PerkinElmer Inc, Annual Ratios (Cont...2)
PerkinElmer Inc, Interim Ratios
PerkinElmer Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
PerkinElmer Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
PerkinElmer Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

PerkinElmer Inc, Performance Chart (2016 - 2020)
PerkinElmer Inc, Ratio Charts
PerkinElmer Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
PerkinElmer Inc, Medical Equipment, Deals by Type, 2015 to YTD 2021